Abstract:Background: Acanthamoeba species can cause devastating contact lens (CL)-related microbial keratitis. Its culture is less sensitive, and little evidence is available for the safety or efficacy profile of medications. Therefore, early diagnosis and optimal treatment remain difficult. The aim of this study was to present the hypothesis that a novel chitosan-coated CL-based ophthalmic drug delivery system has therapeutic and prophylactic effects on acanthamoeba keratitis. Hypothesis: CL-based drug delivery is a popular sustained-release drug delivery that extends the drug release time, thus increasing its bioavailability and treatment efficacy. Chitosan, a derivative of chitin, has antioxidant and broad-spectrum antimicrobial properties against fungi, yeasts, and bacteria. It acts against microbial cells; however, whether its mechanism of action is microbiostatic or microbicidal remains unknown. It exhibits wound healing and film-forming properties. Chitosan composite films permit high transmittance of visible light, making it transparent and therefore desirable for the development of CLs. Chitosan/Ag/ZnO blend films exhibit antimicrobial activities. Further, soft CLs coated with chitosan, sodium hyaluronate, polylysine hydrobromide, and sodium alginate show drug delivery properties and reduced bacterial growth. Recently, concentration-dependent anti-amoebic activities of chitosan and nano-chitosan against the trophozoite and cystic forms of Acanthamoeba have been reported. Based on the existing evidence, we hypothesized that a chitosan-coated CL-based ophthalmic drug delivery system could have therapeutic and prophylactic effects on acanthamoeba keratitis or subsequent endophthalmitis. Conclusions: CLs or intraocular implants with chitosan-based nanocoatings alone or in combination with routine treatment may be preventive or therapeutic for acanthamoeba keratitis or endophthalmitis. Experimental studies and further clinical trials are required to explore the efficacy and safety profile. Moreover, randomized controlled trials in healthy eyes with soft or hard CLs or orthokeratology lenses for refractive error correction may shed light on the prophylactic effect of this novel drug delivery system. Other forms of ophthalmic drug delivery systems using chitosan-based nanocoatings should be studied additionally.

Design of eddy current sensor IC for large displacement

Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs

Acanthamoeba Keratitis, Pathology, Diagnosis and Treatment

An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment

Dopamine, dobutamine, digitalis, and diuretics during intraaortic balloon support.

Novel Effective Medical Therapy for Acanthamoeba Keratitis

Acanthamoeba keratitis: an emerging disease gathering importance worldwide?

Susceptibility of Acanthamoeba to multipurpose lens-cleaning solutions

Epidemiology of and Genetic Factors Associated with Acanthamoeba Keratitis

Diagnostic Considerations for Non-Acanthamoeba Amoebic Keratitis and Clinical Outcomes

Challenges in Acanthamoeba Keratitis: A Review

Diagnosis and Management of Acanthamoeba Keratitis: A Continental Approach

Critical current densities and activation energy of BiPbSrCaCuO tapes

The Effect of Anti-Amoebic Agents and Ce6-PDT on Acanthamoeba castellanii Trophozoites and Cysts, In Vitro

The role of domestic tap water on Acanthamoeba keratitis in non-contact lens wearers and validation of laboratory methods

Evaluating the Diagnostic Potential of Chorismate Mutase Poly-Clonal Peptide Antibody for the Acanthamoeba Keratitis in an Animal Model

Acanthamoeba keratitis – Clinical signs and potential specific conservative treatment

Increasing incidence of contact-lens-related Acanthamoeba keratitis in a tertiary ophthalmology department in an Italian population

Chitosan-coated contact lens-based ophthalmic drug delivery system to manage Acanthamoeba keratitis: a preliminary hypothesis

Decreased stability of photosystem I in dgd1 mutant of Arabidopsis thaliana

Can Acanthamoeba keratitis be properly diagnosed without culture in the real-world clinical microbiology laboratory?: a case report